Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Mar 26;13(4):1083. doi: 10.3390/nu13041083

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Faecal calprotectin and CRP levels from weeks 15 to 52. During follow-up all patients were treated with infliximab. Data are presented as estimated medians with 95% confidence interval (CI). (A) Faecal calprotectin levels in Group D- were 3.8 times higher at both week 15 and week 23 compared to group D+. At weeks 31 and 52, calprotectin levels were not significantly different between the two groups. The overall median curves of the two groups tended to be non-parallel (mixed model, p = 0.1). (B) Median curves for CRP levels over time were close to parallel, but shifted. Group D- had a 2.2 times higher median curve compared with group D+ (p = 0.04).